Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
135.90
+3.86 (2.92%)
At close: Nov 9, 2026, 4:00 PM EST
136.00
+0.10 (0.07%)
Pre-market: Nov 10, 2026, 4:58 AM EST
Protagonist Therapeutics Market Cap
Protagonist Therapeutics has a market cap or net worth of $8.87 billion as of November 9, 2026. It is the 2,344th most valuable company in the world and the 827th biggest in the United States. Its market cap has increased by 78.39% in one year.
Market Cap
8.87B
Enterprise Value
8.04B
1-Year Change
78.39%
Global Rank
Country Rank
#827 United States
Category
ChartMarket Cap Chart
Since August 11, 2016, Protagonist Therapeutics's market cap has increased from $171.50M to $8.87B, an increase of 5,072.13%. That is a compound annual growth rate of 46.94%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 9, 2026 | 8.87B | 62.46% |
| Dec 31, 2025 | 5.46B | 137.34% |
| Dec 31, 2024 | 2.30B | 73.94% |
| Dec 29, 2023 | 1.32B | 146.39% |
| Dec 30, 2022 | 536.80M | -67.11% |
| Dec 31, 2021 | 1.63B | 111.63% |
| Dec 31, 2020 | 771.30M | 302.14% |
| Dec 31, 2019 | 191.80M | 17.81% |
| Dec 31, 2018 | 162.80M | -61.78% |
| Dec 29, 2017 | 426.00M | 15.89% |
| Dec 30, 2016 | 367.60M | 114.34% |
| Aug 11, 2016 | 171.50M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Madrigal Pharmaceuticals | 9.28B |
| ImmunityBio | 9.15B |
| Krystal Biotech | 8.92B |
| TG Therapeutics | 8.49B |
| Arrowhead Pharmaceuticals | 8.22B |
| Corcept Therapeutics | 7.96B |
| Rhythm Pharmaceuticals | 7.78B |
| Praxis Precision Medicines | 7.75B |